Melasma is one of the most stubborn pigmentation conditions to treat, but a combination of topical products, sun protection, and in some cases oral medication or procedures can significantly lighten the patches. No single treatment works for everyone, and the condition tends to recur, so managing melasma is typically an ongoing process rather than a one-time fix.
The dark patches form because melanocytes in the affected skin become hyperactive, producing and transferring excess pigment throughout the outer layer of skin. Three forces drive this process: UV exposure, hormonal shifts (especially estrogen and progesterone), and chronic sun damage that changes the behavior of surrounding skin cells. Effective treatment targets pigment production while controlling those triggers.
Sunscreen Alone Isn’t Enough
Sun protection is the single most important part of any melasma treatment plan, and it needs to go beyond a standard SPF. UV radiation directly stimulates pigment-producing cells and also triggers surrounding cells to release chemical signals that ramp up melanin production even further. Chronic sun exposure actually changes fibroblasts in the deeper skin layers, pushing them into a state where they continuously secrete pigment-promoting and inflammatory compounds. Without rigorous sun protection, every other treatment you use will be undermined.
Here’s the detail most people miss: visible light (the 400 to 700 nanometer range that makes up about 45% of solar radiation) also darkens melasma, and conventional sunscreens provide limited protection against it. Standard mineral or chemical SPF filters block UV but let visible light through. For melasma, you need a sunscreen or tinted moisturizer that contains iron oxides, which absorb and reflect visible light. In people with medium to dark skin tones (Fitzpatrick type III and above), iron oxide formulations significantly reduce visible light pigmentation compared to even high-SPF mineral sunscreens without tint. A tinted sunscreen with broad-spectrum SPF 30 or higher, reapplied every two hours during sun exposure, is the baseline for every other treatment to work.
First-Line Topical Treatments
The gold standard topical for melasma is a triple combination cream containing three active ingredients: hydroquinone at 4%, tretinoin at 0.05%, and a mild steroid (fluocinolone acetonide at 0.01%). This is sold under the brand name Tri-Luma in the U.S. and requires a prescription. Hydroquinone suppresses the enzyme that drives pigment production. Tretinoin speeds cell turnover so pigmented cells are shed faster. The steroid reduces irritation from the other two ingredients and has its own mild depigmenting effect.
This combination is more effective than any of its individual components used alone. Most dermatologists recommend applying it nightly to affected areas for 8 to 12 weeks, then reassessing. One important caution with hydroquinone: prolonged, continuous use over many months or years has been linked to a paradoxical darkening condition called exogenous ochronosis, where abnormal pigment deposits form in the deeper layers of skin. This is why hydroquinone is typically used in cycles rather than indefinitely, often alternating with non-hydroquinone treatments during maintenance phases.
Hydroquinone-Free Alternatives
If you can’t use hydroquinone or prefer to avoid it, several other topicals can help. Cysteamine cream works through multiple pathways: it blocks the same pigment-producing enzyme that hydroquinone targets, shifts melanin production toward a lighter type of pigment, and scavenges chemical precursors that would otherwise feed into the pigmentation process. It also chelates iron and copper, metals involved in pigment synthesis. Cysteamine is available over the counter in some formulations and has shown meaningful improvement in clinical studies.
Other effective non-hydroquinone options include azelaic acid (typically at 15% to 20%), vitamin C serums, niacinamide, and arbutin. Tretinoin on its own, even without hydroquinone, helps by accelerating the turnover of pigmented skin cells. These alternatives generally work more slowly than the triple combination cream but carry fewer risks with long-term use, making them good choices for maintenance therapy.
Oral Tranexamic Acid
For melasma that doesn’t respond well enough to topical treatment alone, oral tranexamic acid has become one of the most promising additions in recent years. This medication, originally used to control bleeding, works in melasma by interrupting the signaling between UV-damaged skin cells and melanocytes. It reduces the chemical triggers that tell pigment cells to ramp up production.
A network meta-analysis of six randomized controlled trials (covering nearly 600 patients) found the optimal dose to be 250 mg taken three times daily for 12 consecutive weeks. For people who have trouble sticking to three daily doses, 250 mg twice daily is a reasonable alternative. Treatment duration in the studies ranged from 8 to 12 weeks, with patients aged 30 to 47 on average. Results are typically visible by 8 weeks. Because tranexamic acid affects clotting, it’s not appropriate for everyone, particularly people with a history of blood clots or those taking hormonal contraceptives that already raise clotting risk.
Chemical Peels
Superficial chemical peels can complement topical regimens by removing the outermost pigmented layers of skin and allowing treatments to penetrate more effectively. Glycolic acid (typically at 30% to 35%) and salicylic acid (at 20% to 30%) are the most commonly used peeling agents for melasma. Both are considered safe for darker skin tones when concentrations are carefully chosen, which matters because melasma disproportionately affects people with more pigmented skin who are also more vulnerable to post-inflammatory darkening from aggressive treatments.
Peels are done in a series, usually every two to four weeks, and work best as an add-on to a topical regimen rather than a standalone treatment. Your provider will start at a lower concentration and increase gradually based on how your skin responds. The goal is to accelerate pigment removal without triggering inflammation that could worsen the discoloration.
Laser and Light Treatments
Lasers occupy a complicated place in melasma treatment. The most studied option is the low-fluence Q-switched Nd:YAG laser, which uses a 1064 nm wavelength at low energy settings to gently break up pigment without causing significant inflammation. A typical course involves 5 to 15 sessions (usually around 10), done weekly or biweekly. Studies show favorable outcomes on both patient satisfaction and objective pigment measurements.
The catch is recurrence. Multiple studies have found that melasma returns in the majority of patients within three months after finishing laser treatment, with recurrence rates ranging from 64% to 100% depending on the study. Immediate side effects are usually mild: temporary redness and swelling after each session. The more concerning risks are mottled hypopigmentation (irregular light spots) and rebound darkening, both of which are more common in darker skin. Approximately 10% of East Asian patients in some studies developed persistent mottled lightening, particularly when cumulative laser energy was high.
For these reasons, lasers are generally reserved for melasma that hasn’t responded to topical and oral treatments. They work best when combined with ongoing topical therapy and strict sun protection rather than used in isolation.
Why Melasma Keeps Coming Back
Melasma is a chronic condition, not a one-time problem to solve. The underlying tendency for melanocytes in affected areas to overproduce pigment doesn’t go away, even when the skin looks clear. UV exposure, hormonal fluctuations from pregnancy or contraceptives, and even heat can reactivate it. This is why dermatologists emphasize maintenance therapy: after an initial treatment phase clears the pigment, stepping down to a gentler long-term regimen (a non-hydroquinone brightening agent plus rigorous tinted sunscreen) helps keep it from returning as quickly.
The most effective approach combines multiple strategies. A realistic plan might look like: a triple combination cream for the first 8 to 12 weeks, transitioning to a maintenance topical like cysteamine or azelaic acid, with oral tranexamic acid added during flare-ups, and iron oxide sunscreen used daily without exception. Treating melasma is less about finding the single right product and more about layering complementary treatments while controlling the triggers that keep the cycle going.